Press Releases
* Please note that the news release contains the content at the time of the announcement and may differ from the latest information.
Euglena and Takeda
Concluding a comprehensive alliance agreement for Euglena
Euglena Co., Ltd.
Takeda Pharmaceutical Company Limited
Euglena Co., Ltd. (Headquarters: Bunkyo-ku, Tokyo, President Mitsuru Izumo, hereinafter "Euglena") and Takeda Pharmaceutical Company Limited (Headquarters: Chuo-ku, Osaka, President Christophe Weber, hereinafter "Takeda Pharmaceutical") We are pleased to announce that we have signed a comprehensive alliance agreement to jointly consider the possibility of developing a new product containing Euglena
Euglena is a kind of algae, and it is a material that has been attracting attention in recent years due to its high functionality, abundant nutrients, and high digestibility of paramylon, which is a kind of β-glucan and has a unique content. Euglena, Inc., the world's first Euglena biotechnology company that has established an outdoor mass culture technology, Euglena we are promoting the research on functionality and application of the material.
Based on this agreement, Euglena Euglena (or paramilon, which is a unique ingredient) in over-the-counter drugs, non-pharmaceutical products, foods (foods for specified health use / nutritionally functional foods and so-called health foods). We will jointly consider the development possibilities of new products. In this joint study, if the theme of commercialization becomes concrete, we will individually conclude a contract for the product to be developed.
Mitsuru Izumo, President and CEO of Our Euglena is an ideal material for adjusting the nutritional balance that modern people tend to have, and its high functionality is expected to be useful not only for foods but also for pharmaceuticals. As a pioneer company in Euglena research, we have signed a contract with Takeda Pharmaceutical, which has developed pharmaceuticals for more than 230 years and has high expertise. We will further aim to contribute to people's health. ".
Masafumi Sugimoto, President of Takeda's Healthcare Company, said, "We have been supporting people's health through medicines under the mission of" contributing to people's health and the future of medical care through the creation of superior medicines. " was. Our management philosophy of "the health of the people and the Earth" is, overlaps with the basic spirit of the Company's management. our company, Euglena with a focus on paramylon with the company Euglena studying the functionality of, the We would like to contribute more to people's health through the products created as a result. "
<About Euglena
- Euglena (Japanese name: Euglena) is a kind of algae like wakame seaweed, kelp, and chlorella.
- It has the characteristics of both animals and plants, and it not only photosynthesizes to produce nutrients like plants, but also has animal nutrients because it exercises like animals.
- It contains 59 kinds of nutrients such as vitamins, minerals, amino acids and unsaturated fatty acids in a well-balanced manner.
- Paramylon, a component unique to Euglena and a type of β-glucan, has a sponge-like porous structure and has the function of adsorbing excessively ingested oil.
59 kinds of nutrients
| Vitamins | α-carotene, β-carotene, vitamin B1, vitamin B2, vitamin B6, vitamin B12, vitamin C, vitamin D, vitamin E, vitamin K1, niacin, pantothenic acid, biotin, folic acid |
|---|---|
| Minerals | Manganese, torso, iron, zinc, calcium, magnesium, potassium, phosphorus, sodium |
| Amino acids | Valine, leucine, isoleucine, alanine, arginine, lysine, aspartic acid, glutamic acid, proline, threonine, methionine, phenylalanine, histidine, tyrosine, tryptophan, glycine, serine, cystine |
| Unsaturated fatty acids | DHA, EPA, palmitoleic acid, oleic acid, linoleic acid, linolenic acid, eicosadonic acid, arachidonic acid, docosatetraenoic acid, docosapentaenoic acid, dihomo γ-linolenic acid |
| Other | Paramylon (β-glucan), chlorophyll, lutein, zeaxanthin, GABA, spermidine, putrescine |
<About Euglena >
In 2005, Euglena succeeded in establishing the world's first outdoor mass culture technology for the microalgae Euglena (Japanese name: Euglena). We develop and sell functional foods and cosmetics using Euglena, and also conduct research for water purification and biofuel production. Listed on TSE Mothers in December 2012.
<About Takeda>
Takeda aims to become a global R & D-type pharmaceutical company by strengthening its own R & D, promoting life cycle management, and actively developing introductions and alliances to enhance its R & D pipeline. We are striving to contribute to the future of people's health and medical care through the creation of superior pharmaceutical products. For more information about http://www.takeda.co.jp/ please visit.
-Contact for inquiries from the press-
Euglena Co., Ltd. Public Relations and IR Division